Today, the life sciences industry is at a critical inflection point. Its public profile has elevated due to its success at quickly developing vaccines to combat the COVID-19 pandemic. It has also built up a lot of trust. Despite the persistent issue of vaccine hesitancy, health -- including life sciences -- rose up in the rankings to become the second most trusted sector after technology, according to the 2021 Edelman Trust Barometer.[1] While the life sciences industry rightly has the approval and trust of its stakeholders -- including heath companies, insurers, clinicians and patients -- such approbation gives rise to an important challenge going forward.
Jan-25-2022, 21:03:27 GMT